Literature DB >> 30604396

The added prognostic value of radiological phenotype combined with clinical features and molecular subtype in anaplastic gliomas.

Minsu Lee1, Kyunghwa Han2, Sung Soo Ahn3, Sohi Bae2, Yoon Seong Choi2, Je Beom Hong4, Jong Hee Chang5, Se Hoon Kim6, Seung-Koo Lee2.   

Abstract

PURPOSE: To determine whether radiological phenotype can improve the predictive performance of the risk model based on molecular subtype and clinical risk factors in anaplastic glioma patients.
METHODS: This retrospective study was approved by our institutional review board with waiver of informed consent. MR images of 86 patients with pathologically diagnosed anaplastic glioma (WHO grade III) between January 2007 and February 2016 were analyzed according to the Visually Accessible Rembrandt Images (VASARI) features set. Significant imaging findings were selected to generate a radiological risk score (RRS) for overall survival (OS) and progression-free survival (PFS) using the least absolute shrinkage and selection operator (LASSO) Cox regression model. The prognostic value of RRS was evaluated with multivariate Cox regression including molecular subtype and clinical risk factors. The C-indices of multivariate models with and without RRS were compared by bootstrapping.
RESULTS: Eight VASARI features contributed to RRS for OS and six contributed to PFS. Multifocality or multicentricity was the most influential feature, followed by restricted diffusion. RRS was significantly associated with OS and PFS (P < .001), as well as age and molecular subtype. The multivariate model with RRS demonstrated a significantly higher predictive performance than the model without (C-index difference: 0.074, 95% confidence interval [CI]: 0.031, 0.148 for OS; C-index difference: 0.054, 95% CI: 0.014, 0.123 for PFS).
CONCLUSION: RRS derived from VASARI features was an independent predictor of survival in patients with anaplastic gliomas. The addition of RRS significantly improved the predictive performance of the molecular feature based model.

Entities:  

Keywords:  Anaplastic glioma; IDH mutation; Imaging biomarker; LASSO; Molecular subtype; VASARI

Mesh:

Substances:

Year:  2019        PMID: 30604396     DOI: 10.1007/s11060-018-03072-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  4 in total

Review 1.  Radiological differences between subtypes of WHO 2016 grade II-III gliomas: a systematic review and meta-analysis.

Authors:  Djuno I van Lent; Kirsten M van Baarsen; Tom J Snijders; Pierre A J T Robe
Journal:  Neurooncol Adv       Date:  2020-04-04

2.  A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma.

Authors:  Tengfei Qi; Xiangqi Meng; Zhenyu Wang; Xinyu Wang; Nan Sun; Jianguang Ming; Lejia Ren; Chuanlu Jiang; Jinquan Cai
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

3.  [MRI reporting of gliomas : What neuro-oncology clinicians expect from radiologists].

Authors:  Torge Huckhagel; Christian Riedel
Journal:  Radiologie (Heidelb)       Date:  2022-05-25

4.  Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.

Authors:  Eun Kyoung Hong; Seung Hong Choi; Dong Jae Shin; Sang Won Jo; Roh Eul Yoo; Koung Mi Kang; Tae Jin Yun; Ji Hoon Kim; Chul Ho Sohn; Sung Hye Park; Jae Kyoung Won; Tae Min Kim; Chul Kee Park; Il Han Kim; Soon Tae Lee
Journal:  Korean J Radiol       Date:  2020-09-10       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.